financetom
Business
financetom
/
Business
/
Spectral AI Partners With PolyNovo to Deploy Burn Wound Diagnostics System in Australia
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Spectral AI Partners With PolyNovo to Deploy Burn Wound Diagnostics System in Australia
Jul 8, 2024 6:51 AM

09:38 AM EDT, 07/08/2024 (MT Newswires) -- Spectral AI (MDAI) said Monday it has signed a memorandum of understanding with PolyNovo to deploy Spectral's AI-based wound diagnostics platform DeepView for burn wound assessment at two hospitals in Australia.

The company said DeepView uses AI and multispectral imaging to provide immediate assessment of the healing potential of a burn wound.

Under the agreement, burn treatment products developer PolyNovo will support Spectral AI's application to the Australian Special Access Scheme for the deployment of up to two DeepView systems at Royal Adelaide Hospital and The Alfred Hospital in Melbourne, Spectral AI said.

This initial deployment is intended to prepare for a broader commercial rollout based on clinician feedback, Spectral added.

Shares of the company were up 1.6% in early trading Monday.

Price: 1.9500, Change: +0.03, Percent Change: +1.56

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Titan Pharmaceuticals Announces Closing Of Merger With Black Titan Corporation
BRIEF-Titan Pharmaceuticals Announces Closing Of Merger With Black Titan Corporation
Oct 3, 2025
Oct 3 (Reuters) - Black Titan Corp ( BTTC ): * TITAN PHARMACEUTICALS, INC. ANNOUNCES CLOSING OF MERGER WITH BLACK TITAN CORPORATION Source text: Further company coverage: ...
AI chip firm Cerebras Systems files to withdraw its highly anticipated US listing
AI chip firm Cerebras Systems files to withdraw its highly anticipated US listing
Oct 3, 2025
Oct 3 (Reuters) - AI chip startup Cerebras Systems, which competes with industry leader Nvidia ( NVDA ) in the booming AI chip market, on Friday filed to withdraw its plans for an initial public offering in the United States, effective immediately. Its withdrawal comes as U.S. IPO activity picks up in recent months, reversing an earlier slowdown caused by...
Corcept Therapeutics Insider Sold Shares Worth $3,403,253, According to a Recent SEC Filing
Corcept Therapeutics Insider Sold Shares Worth $3,403,253, According to a Recent SEC Filing
Oct 3, 2025
05:29 PM EDT, 10/03/2025 (MT Newswires) -- Joseph K Belanoff, Director, Chief Executive Officer, on October 01, 2025, sold 40,000 shares in Corcept Therapeutics ( CORT ) for $3,403,253. Following the Form 4 filing with the SEC, Belanoff has control over a total of 2,781,370 common shares of the company, with 2,781,370 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000119312525230467/xslF345X05/ownership.xml ...
Alnylam Pharmaceuticals Insider Sold Shares Worth $2,692,062, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $2,692,062, According to a Recent SEC Filing
Oct 3, 2025
05:23 PM EDT, 10/03/2025 (MT Newswires) -- Pushkal Garg, Executive Vice President, Chief Research and Development Officer, on October 01, 2025, sold 5,959 shares in Alnylam Pharmaceuticals ( ALNY ) for $2,692,062. Following the Form 4 filing with the SEC, Garg has control over a total of 20,902 common shares of the company, with 20,221 shares held directly and 681...
Copyright 2023-2026 - www.financetom.com All Rights Reserved